Profile avatar
drpallaviprasad.bsky.social
Nephrologist 🩺 Assistant Professor 📚 Bookworm 🐛 Amateur gardener 🪴Travel enthusiast 🧳
97 posts 491 followers 86 following
Regular Contributor
Active Commenter
Posts 15 Comments 35

#NephJC

submitted 5 days ago • 0 comments

Hi everyone! Good morning from Kerala, God's own country. will be lurking today. COI: flozinator >> RAASblocker

submitted 5 days ago • 2 comments

From Rivka Galchen’s article in @newyorker.com: “The kidney, a tremendously under-celebrated organ, basically does four-dimensional sudoku with ions.” And that’s how I’m going to explain it from now on.

submitted 7 days ago • 1 comment

Hilarious (and sobering) essay on the use of AI in medical research & manuscript writing Read the whole thing! John Daugirdas has been on the cutting edge of tech in meded before #MedEd was thing onlinelibrary.wiley.com/doi/10.1111/... #MedSky #NephSky

submitted 17 days ago • 4 comments

1/10 Last #NephJC we discussed the role of prophylactic DDAVP for preventing post kidney biopsy (KBx) bleed #TenPostNephJC . The articles 👇 @kireports.bsky.social @asnpublications.bsky.social @jeyakumarmeyyappan.bsky.social www.kireports.org/article/S246... pubmed.ncbi.nlm.nih.gov/40067357/

submitted 39 days ago • 1 comment

Don´t forget to advocate the resolution led by Guatemala on #WHA78: 🌍 Chronic kidney disease affects over 850M We must shift from silent neglect to strategic action. Awareness, prevention, and equity in care are our next steps. #NephJC @theisn.org #NephSky #MedSky www.thelancet.com/jo...

submitted 47 days ago • 1 comment

Hi everyone! Pallavi from New Delhi. No COI. Have used desmopressin for high risk patients #Nephjc

submitted 47 days ago • 2 comments

Alright #PedNeph #NephTwitter ⁦‪#NephJC What do you think? Truly a comparative effectiveness trial? Tacrolimus or Mycophenolate Mofetil for Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome: A Randomized Clinical Trial jamanetwork.com/journals/jam...

submitted 48 days ago • 1 comment

1/10 We were delighted to discuss the first ever @KDIGO ADPKD guidelines this March! So satisfied with the chat itself that we forgot to post the #TenPostsNephJC 😉 So here we are! Better late than never.#NephJC kdigo.org/guidelines/a...

submitted 53 days ago • 1 comment

We are pleased to announce the publication of the KDIGO 2025 Guideline for Nephrotic Syndrome in Children—an update to Chapter 4 of the KDIGO 2021 Glomerular Diseases Guideline. 📄 Read in @kidneyint.bsky.social: kdigo.co/Nephrotic-Sy... 🧵More below ⬇️

submitted 73 days ago • 1 comment

T3c: #nephjc 🔸7% survival boost with continued metformin in CKD4+ challenges current restrictions 🔸Benefit persists despite observational design, bolstered by rigorous target-trial methods 🔸Aligns with prior data showing glycemic deterioration post-discontinuation

submitted 75 days ago • 2 comments

T0i: #NephJC Evidence supporting strict metformin discontinuation in CKD is limited. MALA risk it’s the "acid-ental perfect storm" made by pH and low eGFR. It often occurs with acute stressors like heart failure, sepsis, shock, or AKI, which can happen at any GFR

submitted 75 days ago • 4 comments

Hi everyone! Late to #NephJC and lurking today despite being really interested in this topic. Recovering from a bad viral 🤕. No COI.

submitted 75 days ago • 1 comment

Hey #NephSky & #MedSky 9pm EST 4/15/25, only on #Bluesky Discussion on the use of metformin in advanced CKD. Worried about lactic acidosis 💪?! What's the evidence that an eGFR < 30 ml/min is the ideal cutoff ✂️? Are there benefits to continuing 💊 www.nephjc.com/news/metformin-tte

submitted 76 days ago • 2 comments

Hey #NephSky and #MedSky Check out the VA for our discussion 4/15/25 at 9pm EST Metformin-Should I Stay or Should I Go (in patients with advanced CKD) VA by @nephroseeker.medsky.social www.nephjc.com/news/metformin-ckd-va

submitted 76 days ago • 0 comments